| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Division of Dermatology, Department of Medicine, University of California San Diego and VA San Diego Healthcare Center, San Diego;
Division of Infectious Disease, Department of Pediatrics, University of California San Diego, San Diego, California, USA;
Cellular and Molecular Microbiology Division, Medical Microbiology and Hygiene Department, University of Tubingen, Tubingen, Germany; and
Institute of Basic Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan
1Correspondence: Mail Code 9111B, 3350 La Jolla Village Dr., San Diego, CA 92161, USA. E-mail: rgallo{at}vapop.ucsd.edu
Antimicrobial peptides (AMPs) have been shown in animal and human systems to be effective natural antibiotics. However, it is unclear how they convey protection; they often appear inactive when assayed under culture conditions applied to synthetic antibiotics. This inactivation has been associated with loss of function in physiological concentrations of NaCl or serum. In this study we show that the balance of host ionic conditions dictate microbial sensitivity to AMPs. Carbonate is identified as the critical ionic factor present in mammalian tissues that imparts the ability of AMPs such as cathelicidins and defensins to kill at physiological NaCl concentrations. After adapting to carbonate-containing solutions, global changes occur in Staphylococcus aureus and Escherichia coli structure and gene expression despite no change in growth rate. Our findings show that changes in cell wall thickness and Sigma factor B expression correspond to the increased susceptibility to the AMP LL-37. These observations provide new insight into the factors involved in enabling function of innate immune effector molecules, and suggest that discovery of new antimicrobials should specifically target pathogens as they exist in the host and not the distinctly different phenotype of bacteria grown in culture broth.—Dorschner, R. A., Lopez-Garcia, B., Peschel, A., Kraus, D., Morikawa, K., Nizet, V., Gallo, R. L. The mammalian ionic environment dictates microbial susceptibility to antimicrobial defense peptides.
Key Words: leukocyte recruitment • cathelicidin • AMP activity • dermatitis
This article has been cited by other articles:
|
|
 |
|
  G. Diamond, N. Beckloff, and L.K. Ryan Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences Journal of Dental Research, October 1, 2008; 87(10): 915 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Harder, R. Glaser, and J.-M. Schroder Review: Human antimicrobial proteins effectors of innate immunity Innate Immunity, December 1, 2007; 13(6): 317 - 338. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Tohyama, K. Sayama, H. Komatsuzawa, Y. Hanakawa, Y. Shirakata, X. Dai, L. Yang, S. Tokumaru, H. Nagai, S. Hirakawa, et al. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes Int. Immunol., September 1, 2007; 19(9): 1095 - 1102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. G. Chan, M. Mayer, E. M. Davis, S. A. Halperin, T.-J. Lin, and S. F. Lee Role of D-Alanylation of Streptococcus gordonii Lipoteichoic Acid in Innate and Adaptive Immunity Infect. Immun., June 1, 2007; 75(6): 3033 - 3042. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Martineau, K. A. Wilkinson, S. M. Newton, R. A. Floto, A. W. Norman, K. Skolimowska, R. N. Davidson, O. E. Sorensen, B. Kampmann, C. J. Griffiths, et al. IFN-{gamma}- and TNF-Independent Vitamin D-Inducible Human Suppression of Mycobacteria: The Role of Cathelicidin LL-37 J. Immunol., June 1, 2007; 178(11): 7190 - 7198. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Brissette and S. A. Lukehart Mechanisms of Decreased Susceptibility to {beta}-Defensins by Treponema denticola Infect. Immun., May 1, 2007; 75(5): 2307 - 2315. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bergman, L. Johansson, H. Wan, A. Jones, R. L. Gallo, G. H. Gudmundsson, T. Hokfelt, A.-B. Jonsson, and B. Agerberth Induction of the Antimicrobial Peptide CRAMP in the Blood-Brain Barrier and Meninges after Meningococcal Infection Infect. Immun., December 1, 2006; 74(12): 6982 - 6991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Rudolph, R. Podschun, H. Sahly, S. Schubert, J. M. Schroder, and J. Harder Identification of RNase 8 as a Novel Human Antimicrobial Protein. Antimicrob. Agents Chemother., September 1, 2006; 50(9): 3194 - 3196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Steffen, S. Rieg, I. Wiedemann, H. Kalbacher, M. Deeg, H.-G. Sahl, A. Peschel, F. Gotz, C. Garbe, and B. Schittek Naturally processed dermcidin-derived peptides do not permeabilize bacterial membranes and kill microorganisms irrespective of their charge. Antimicrob. Agents Chemother., August 1, 2006; 50(8): 2608 - 2620. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
